Related Experiment Videos

Antibiotic resistance and penicillin tolerance in clinical isolates of group B streptococci

C Betriu1, M Gomez, A Sanchez

  • 1Servicio de Microbiología Clínica, Hospital Universitario San Carlos, Madrid, Spain.

Insights

Penicillin tolerance is common in hospital-acquired group B streptococci (GBS). This study found 17% of GBS strains exhibited penicillin tolerance, suggesting potential treatment challenges.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Group B Streptococcus (GBS) is a significant cause of neonatal infections.
  • Penicillin is the recommended treatment for GBS infections.
  • Understanding antimicrobial susceptibility and tolerance is crucial for effective treatment.

Purpose of the Study:

  • To determine the penicillin susceptibility patterns of 100 clinical isolates of group B Streptococcus.
  • To assess the tolerance of GBS strains to penicillin using quantitative killing curves.

Main Methods:

  • Isolation and identification of 100 group B streptococcal strains from clinical samples.
  • Determination of minimum inhibitory concentrations (MICs) for penicillin and ampicillin.
  • Quantitative killing curve assays to assess bacterial killing kinetics over 24 hours.

Main Results:

  • Two strains showed intermediate susceptibility to penicillin, and eight strains to ampicillin.
  • Seventeen isolates (17%) were found to be tolerant to penicillin.
  • Penicillin-tolerant strains showed a 2-3 log decrease in bacterial count within 8 hours, but remained above 10^2 CFU/ml after 24 hours.

Conclusions:

  • Penicillin tolerance is a notable phenomenon among group B streptococci isolated in this hospital.
  • The prevalence of penicillin tolerance suggests potential challenges in eradicating GBS infections with penicillin therapy.
  • Further research into the mechanisms and clinical implications of GBS penicillin tolerance is warranted.

Related Concept Videos